Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide

Equine Veterinary Journal

Volumn 34, Issue 7, 2002, Pages 679-685

  Perkins, G A ^a   Lamb, S ^b   Erb, H N ^b   Schanbacher, B ^b   Nydam, D V ^b   Divers, T J ^a  

^a Department of Obstetrics Gynecology   (United States)

^b Animal Health Diagnostic Center   (United States)

Author keywords

Cyproheptadine; Equine cushing's disease; Horse; Pars intermedia; Pergolide; Pituitary adenoma; Pituitary hyperplasia

Indexed keywords

CYPROHEPTADINE; PERGOLIDE; CORTICOTROPIN;

ACCURACY; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; CUSHING DISEASE; HORMONE BLOOD LEVEL; HORSE; NONHUMAN; TREATMENT OUTCOME; VALIDATION PROCESS; ANIMAL; ANIMAL DISEASE; BLOOD; CUSHING SYNDROME; DRUG MONITORING; FEMALE; HORSE DISEASE; MALE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

EQUIDAE; EQUUS CABALLUS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CHEMILUMINESCENT MEASUREMENTS; CUSHING SYNDROME; CYPROHEPTADINE; DRUG MONITORING; FEMALE; HORSE DISEASES; HORSES; MALE; PERGOLIDE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0036835696     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516402776250333     Document Type: Article

References (43)

1. Alexander, S.L , Irvine, C H.G., Ellis, M.J. and Donald, R.A. (1991) Effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin and adrenocortiocotropin as measured in pituitary venous blood from the horse. Endocrinol. 128, 65-72.
2. Beck, D.J. (1992) Effective long-term treatment of a suspected pituitary adenoma with bromocriptine mesylate in a pony. Equine vet. Educ. 4, 119-122
3. Beech, J. (1984) Treatment of hypophyscal adenomas. Comp. cont. Educ pract. Vet. 16, 921-923.
4. Beech, J. (1999) Diseases of the pituitary gland. In: Equine Medicine and Surgery, 5th edn., Eds: P.T. Colahan, A M. Merritt, J.N. Moore and I.G. Mayhew, Mosby Inc., St. Louis. pp 1951-1956
5. Beech, J. and Garcia, M. (1985) Hormonal response to thyrotropin- releasing hormone in healthy horses and in horses with pituitary adenoma. Am J. vet. Res. 46, 1941-1943
6. Couetil, L. (1996) Clinical response and plasma adrenocorticotropin concentration in horses with equine Cushing's disease treated with cyproheptadine. Proc. Am. Ass. equine Practnrs. 42, 297-298.
7. Couetil, L., Paradis, M.R. and Knoll, J. (1996) Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism. J. vet. intern Med. 10, 1-6.
8. Cudd, T.A. Leblanc, M., Silver, M., Norman, W., Madison, J., Keller-Wood, M. and Wood, C.E. (1995) Ontogeny and ultradian rhythms of adrenocorticotropin and cortisol in the late-gestation fetal horse. J. Endocrinol 45, 271-283.
9. Dean, A.G., Dean, J.A., Coulombier, D., Brendel, K.A., Smith, D.C., Burton, A.H., Dicker, R.C., Sullivan, K., Fagan, R.F. and Arner, T.G. (1997) Epi Info. Version 6.04b: A word processing, database and statistics program for public health on IBM-compatible microcomputers. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
10. Donald, R.A. (1967) A rapid method for extracting corticotrophin from plasma. J. Endocrinol 39, 451-452
11. Dybdal, N.O (1996) Endocrine and metabolic diseases. In: Large Animal Internal Medicine, 2nd edn., Ed: B.P. Smith, Mosby-Year Book, Inc., St Louis. pp 1444-1449.
12. Dybdal, N.O., Hargreaves, K.M., Madigan, J.E., Gribble, D.H., Kennedy, P.C. and Stabenfeldt, G H. (1994) Diagnostic testing for pituitary pars intermedia dysfunction in horses. J. Am. vet. med. Ass. 204, 627-632
13. Eiler, H., Oliver, J W., Andrews, F.M , Fecteau, K.A., Green, E.M. and McCracken, M. (1997) Results of a combined dexamethasone suppression/ thyrotropin-releasing hormone stimulation test in healthy horses and in horses suspected to have a pars intermedia pituitary adenoma. J. Am. vet. med. Ass. 211, 79-81.
14. Gutkowska, J , Julesz, J., St-Louis, J and Genest, J. (1982) Radioimmunoassay of corticotropin from plasma. Clin. Chem. 28, 2229-2234.
15. Hegstad, R.L , Johnston, S.D. and Pasternack, D.M. (1990) Effects of sample handling on adrenocorticotrophin concentration measured in canine plasma, using a commercially available radioiummunoassay kit Am. J. vet. Res 51, 1941-1947
16. Heinrichs, M , Baurngartner, W. and Capen, C.C. (1990) Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses. Vet. Path 27, 419-425.
17. Hodson, N.P., Wright, J.A. and Hunt, J. (1986) The sympatho-adrenal system and plasma levels of adrenocorticotropic hormone, cortisol and catecholamines in equine grass sickness. Vet Rec. 118, 148-150.
18. Lambert, A., Frost, J., Ratcliffe, W.A and Robertson, W.R. (1985) On the stability in vitro of bioactive human adrenocorticotrophin in blood and plasma Clin. Endocrinol 23, 253-261.
19. Levy, M. and Dybdal, N O. (1999) Diagnosis and treatment of equine Cushing's disease. Comp. cont. Educ. pract Vet. 21, 766-769.
20. Love, S. (1993) Equine Cushing's disease. Br. vet J. 149, 139-153.
21. Luna, S.P. and Taylor, P.M. (1995) Pituitary-adrenal activity and opioid release in ponies during thiopentone/halothane anaesthesia Res. vet. Sci 58, 35-41.
22. McCarthy, R.N., Jeffcott, L.B , Funder, J.W., Fullerton, M and Clarke, I.J. (1991) Plasma beta-endorphin and adrenocorticotrophin in young horses in training. Aust. vet. J. 68, 359-361.
23. McFarlane, D., Sellon, D.C., Gaffney, D., Hedgpeth, V. and Papich, M. (1998) Hematologic and serum biochemical variables and plasma corticotropin concentration in healthy aged horses. Am. J vet Res. 59, 1247-1251.
24. McGowan, C.M. and Neiger, R. (2001) Efficacy of trilostane in the management of equine Cushing's disease Proc. Am Coll. vet. int Med. 19, 887.
25. Meakin, J.W., Tingey, W.H. and Nelson, D.H. (1960) The catabolism of adrenocorticotropic hormone: the stability of adrenocorticotropic hormone in blood, plasma, serum and saline. Endocrinol. 6, 59-72.
26. Millington, W R , Dybdal, N.O., Dawson, R., Manzini, C and Mueller, G.P. (1988) Equine Cushing's disease, differential regulation of β-endorphin processing in tumors of the intermediate pituitary. Endocrinol. 123, 1598-1604.
27. Moore. J.N., Steiss, I , Nicholson, W.E. and Orth, D.N. (1979) A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in a horse. Endocrinol. 104, 576-582.
28. Nagata, S., Takeda, F., Kurosawa, M., Mima, K., Hiraga, A., Kai, M. and Taya, K. (1999) Plasma adrenocortictropin, cortisol and catecholamines response to various exercises. Equine vet. J., Suppl 30, 570-574
29. Ng, T.B., Chung, D. and Li, C.H. (1981) Isolation and properties of β-endorphin-(1-27), Na-acetyl-β-endorphin, corticotropin, gamma-lipotropin and neurophysin from equine pituitary glands. Int. J. Peptide Protein Res. 18, 443-450.
30. Okada, T , Shimomuro, T., Oikawa, M., Nambo, Y., Kiso, Y., Morikawa, Y., Liptrap, R.M., Yamashiro, S., Little, P.B and Sasaki, F. (1997) Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in Thoroughbreds. Am. J. vet. Res. 58, 920-924
31. Orth, D.N. and Nicholson, W E. (1982) Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease. Endocrinol. 11, 559-563.
32. Orth, D.N., Holscher, M.A., Wilson, M.G., Nicholson, W.E , Plue, R.E. and Mount, C.D. (1982) Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinol 110, 1430-1441
33. Peters, D.F., Erfle, J.B. and Slobojan, G.T. (1995) Low-dose pergolide mesylate treatment for equine hypophyseal adenomas (Cushing's syndrome). Proc. Am. Ass. equine Practnrs. 41, 154-155.
34. Ratcliffe, J.G. and Edwards, C.R W. (1971) The extraction of adrenocorticotrophin and arginine-vasopressin from human plasma by porous glass. In. Radioimmunoassay Methods, Eds: K.E Kirkham and W.M. Hunter, Williams & Wilkins Co., Baltimore. pp 502-512.
35. Redekopp, C., Irbine, C.H G , Donald, R.A., Livesey, J.H., Sadler, W., Nicholls, M.G., Alexander, S.L. and Evans, M.J. (1986) Spontaneous and stimulated adrenocorticotropin and vasopressin pulsatile secretion in the pituitary venous effluent of the horse Endocrinol. 118, 1410-1416.
36. Stouffer, J.E. and Lipscomb, H S. (1963) Reversible binding of ACTH to a glass surface. J. clin. Endocrinol. Metab 72, 91-94
37. Taylor, P.M. (1989) Equine stress response to anaesthesia. Br J. Anaesth. 63, 702-709.
38. Toutain, P.L., Oukessou, M., Autefage, A. and Alvinerie, M. (1988) Diurnal and episodic variations of plasma hydrocortisone concentrations in horses. Domest. anim Endocrinol 5, 55-59.
39. van der Kolk, J H. (1998) Diseases of the pituitary gland, including hyperadrenocortcism. In: Metabolic and Endocrine Problems of the Horse, Ed: T. Watson, W B. Saunders Co., London. pp 41-68
40. van der Kolk, J H (2001) Pituitary-independent Cushing's syndrome in a horse. Equine vet J. 33, 110-112.
41. van der Kolk, J.H., Wensing, T., Kalsbeek, H C and Breuking, H.J. (1995) Laboratory diagnosis of equine pituitary pars intermedia adenoma. Domest. anim. Endocrinol 12, 35-39.
42. Watson, J.L., Dybdal, N O., Herrgesell, E.J., Koblik, P.D. and Madigan, J.E. (1998) Equine Cushing's disease and the long-term treatment with oral pergolide mesylate Proc Am. Coll. vet. Int. Med. 16, 710.
43. Wilson, M.G., Nicholson, W E., Holscher, M.A., Sherrell, B.J., Mount, C D. and Orth, D N. (1982) Propiomelanocortin peptides in normal pituitary, pituitary tumor and plasma of normal and Cushing's horses. Endocrinol 110, 941-954.